跳到正文
原文
Medical Xpress·· 10 天前AI 评分50

没有心脏病史的老年人停用他汀类药物一般安全

Discontinuing statins generally safe for older adults without heart disease

AI 导读

一项新研究发现,70岁及以上且没有心脏病史的老年人停用他汀类药物预防心血管疾病是安全的,但需个体化决策。研究未发现停药后生活质量、肌肉疼痛、跌倒或肌肉减少症有显著差异。

正文
Discontinuing statins generally safe for older adults without heart disease
Heart chambers illustration. Credit: American Heart Association

It is generally safe for adults ages 70 and older who take statins to prevent cardiovascular disease but who have not had a heart attack or stroke to discontinue taking the cholesterol-lowering medications, according to new, independent, preliminary late-breaking science presented Saturday at the American Heart Association's Scientific Sessions 2026 in Chicago.

About 25% of U.S. adults are estimated to have high low-density lipoprotein-cholesterol (LDL-C), or "bad cholesterol," which can build up in the arteries, affecting blood flow and increasing the risk of heart attack and/or stroke. Statin therapy is the foundation of lipid-lowering and risk reduction, which includes primary prevention aimed at preventing a first heart attack or stroke, as detailed in the association's 2026 joint guideline on dyslipidemia.

"While the association's recent joint guideline recommends lifestyle and potentially medication for people with high LDL-C at younger ages to reduce the risk of heart attack and stroke, recent studies question the health benefits of continuing statins in the later decades of life," said study author Rita F. Redberg, M.D., M.Sc., FAHA, professor of cardiology and the Araxe Vilensky Endowed Chair in Cardiology at the University of California, San Francisco School of Medicine.

"A few previous studies assessed the safety of discontinuing statins for primary prevention at age 70 and later, and they found no difference in mortality. One study suggested quality-of-life improvements after stopping statins. Whether it is safe to discontinue statins to prevent a first CVD event in the elderly remained unclear and was the question we explored in our study."

This study included nearly 1,900 adults, ages 70 and older, who took statins to prevent a first cardiovascular event and had at least two chronic health conditions, such as past cancer or pulmonary disease. Half of the participants discontinued taking statins, while the other half continued taking them. The researchers monitored the participants during the next two years, and for up to four years, for heart attack, stroke or death. They also assessed quality of life, muscle pain, falls and muscle wasting (known as sarcopenia).

Key findings

  • At about two years, discontinuation of statins was safe, without a significant increase in heart attack, stroke or death, compared to those who continued the therapy.
  • There were no differences between the groups when researchers assessed the study participants' quality of life, muscle pain, falls and sarcopenia.
  • Statistically speaking, over the course of two years, for every 40 individuals in the group who discontinued statins, one additional cardiovascular event occurred among them.
  • In a follow-up period of up to four years, 12.7% of those who discontinued statins had a heart attack, stroke or death, compared to 9.2% who continued the therapy.

Redberg noted the increased risk at four years among a small number of older adults was a new finding in scientific literature, one which she said could be because this trial had more people and a longer follow-up than previous studies.

"This small, increased risk of cardiovascular events means that one cannot make a general recommendation about stopping statins in this patient population," she said. "There should be shared decision-making between the patient and the health care professional to know if it is appropriate for an individual to discontinue the medication. In general, however, discontinuation is safe for most people who are in this age group and without a previous CVD event."

Study details, background, design and limitations

The research included 1,880 total adults, ages 70 and older (average age of 77; 53% men and 47% women) with at least two chronic health conditions. People with existing cardiovascular disease or a prior cardiovascular event were excluded from the study.

The study was conducted from November 2021 to April 2026 at 24 clinical centers in Switzerland, France and the Netherlands.

Of the participants, 938 were assigned to the group to discontinue statins, and 942 of the participants continued taking their statin medications.

Researchers collected data on heart attack, acute ischemic stroke and all-cause death. In addition, participants were surveyed throughout the study and during follow-up about quality of life, muscle pain, falls and sarcopenia.

A limitation of the study was that there was crossover in both groups during the study period, meaning some people in the discontinuation group restarted their statins while some in the continuation group stopped them. Overall, about 14% of participants crossed over to the other group during the study. To account for this shift, the researchers conducted several additional analyses that yielded no change in the results.

Who's behind this story?

Lisa Lock

Lisa Lock

BA art history, MA material culture. Former museum editor, paramedic, and transplant coordinator. Editing for Science X since 2021. Full profile →

Andrew Zinin

Andrew Zinin

Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →

Citation: Discontinuing statins generally safe for older adults without heart disease (2026, November 9) retrieved 9 November 2026 from https://medicalxpress.com/news/2026-11-discontinuing-statins-generally-safe-older.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com